Immunotherapy (APC8015, Provenge®) targeting prostatic acid phosphatase can induce durable remission of metastatic androgen-independent prostate cancer: A phase 2 trial von Burch, Patrick A., Croghan, Gary A., Gastineau, Dennis A., Jones, Lori A., Kaur, Judith S., Kylstra, Jelle W., Richardson, Ronald L., Valone, Frank H., Vuk-Pavlović, Stanimir

Volltext

A phase II study of ABT-510 (thrombospondin-1 analog) for the treatment of metastatic melanoma von Markovic, Svetomir N, Suman, Vera J, Rao, Ravi A, Ingle, James N, Kaur, Judith S, Erickson, Lori A, Pitot, Henry C, Croghan, Gary A, McWilliams, Robert R, Merchan, Jaime, Kottschade, Lisa A, Nevala, Wendy K, Uhl, Cindy B, Allred, Jacob, Creagan, Edward T

Volltext

Second primary tumors following tobacco dependence treatments among head and neck cancer patients von Garces, Yolanda I, Schroeder, Darrell R, Nirelli, Liza M, Croghan, Gary A, Croghan, Ivana T, Foote, Robert L, Hurt, Richard D

Volltext

Tobacco Use Outcomes Among Patients With Lung Cancer Treated for Nicotine Dependence von COX, Lisa Sanderson, PATTEN, Christi A, EBBERT, Jon O, DREWS, Amanda A, CROGHAN, Gary A, CLARK, Matthew M, WOLTER, Troy D, DECKER, Paul A, HURT, Richard D

Volltext

Effects of Biochemically Confirmed Smoking Cessation on White Blood Cell Count von Abel, Gregory A., Hays, J. Taylor, Decker, Paul A., Croghan, Gary A., Kuter, David J., Rigotti, Nancy A.

Volltext

A phase I study of the VEGFR kinase inhibitor vatalanib in combination with the mTOR inhibitor, everolimus, in patients with advanced solid tumors von Zhu, Mojun, Molina, Julian R., Dy, Grace K., Croghan, Gary A., Qi, Yingwei, Glockner, James, Hanson, Lorelei J., Roos, Michelle M., Tan, Angelina D., Adjei, Alex A.

Volltext

A Phase I Trial of the Farnesyl Protein Transferase Inhibitor R115777 in Combination with Gemcitabine and Cisplatin in Patients with Advanced Cancer von ADJEI, Alex A, CROGHAN, Gary A, BRUZEK, Laura M, ATHERTON, Pamela, THIBAULT, Alain, PALMER, Peter A, KAUFMANN, Scott H, ERLICHMAN, Charles, MARKS, Randolph S, REID, Joel M, SLOAN, Jeff A, PITOT, Henry C, ALBERTS, Steven R, GOLDBERG, Richard M, HANSON, Lorelei J

Volltext

A Phase I Trial of the Novel Farnesyl Protein Transferase Inhibitor, BMS-214662, in Combination with Paclitaxel and Carboplatin in Patients with Advanced Cancer von DY, Grace K, BRUZEK, Laura M, CHENG, Shinta, MARTELL, Robert E, KAUFMANN, Scott H, ADJEI, Alex A, CROGHAN, Gary A, MANDREKAR, Sumithra, ERLICHMAN, Charles, PEETHAMBARAM, Prema, PITOT, Henry C, HANSON, Lorelei J, REID, Joel M, FURTH, Alfred

Volltext

Up-regulation of pro-angiogenic factors and establishment of tolerance in malignant pleural effusions von Lieser, Elizabeth Ann T, Croghan, Gary A, Nevala, Wendy K, Bradshaw, Michael J, Markovic, Svetomir N, Mansfield, Aaron S

Volltext

A Study of Paclitaxel, Carboplatin, and Bortezomib in the Treatment of Metastatic Malignant Melanoma: A Phase 2 Consortium Study von CROGHAN, Gary A, SUMAN, Vera J, MAPLES, William J, ALBERTINI, Mark, LINETTE, Gerald, FLAHERTY, Lawrence, ECKARDT, John, MA, Cynthia, MARKOVIC, Svetomir N, ERLICHMAN, Charles

Volltext

Combination of paclitaxel and carboplatin as second‐line therapy for patients with metastatic melanoma von Rao, Ravi D., Holtan, Shernan G., Ingle, James N., Croghan, Gary A., Kottschade, Lisa A., Creagan, Edward T., Kaur, Judith S., Pitot, Henry C., Markovic, Svetomir N.

Volltext

The prevalence of weight concerns in a smoking abstinence clinical trial von Clark, Matthew M., Hurt, Richard D., Croghan, Ivana T., Patten, Christi A., Novotny, Paul, Sloan, Jeff A., Dakhil, Shaker R., Croghan, Gary A., Wos, Edward J., Rowland, Kendrith M., Bernath, Albert, Morton, Roscoe F., Thomas, Sachdex P., Tschetter, Loren K., Garneau, Stewart, Stella, Philip J., Ebbert, Larry P., Wender, Donald B., Loprinzi, Charles L.

Volltext

Genetic Variations in Multiple Drug Action Pathways and Survival in Advanced Stage Non―Small Cell Lung Cancer Treated with Chemotherapy von YAFEI LI, ZHIFU SUN, LIEWEI WANG, PANKRATZ, V. Shane, PING YANG, CUNNINGHAM, Julie M, AUBRY, Marie C, WAMPFLER, Jason A, CROGHAN, Gary A, JOHNSON, Cassandra, DANLI WU, AAKRE, Jeremiah A, MOLINA, Julian

Volltext

Nicotine Nasal Spray for Smoking Cessation: Pattern of Use, Side Effects, Relief of Withdrawal Symptoms, and Cotinine Levels von Hurt, Richard D., Dale, Lowell C., Croghan, Gary A., Croghan, Ivana T., Gomez-Dahl, Leigh C., Offord, Kenneth P.

Volltext

Randomized Comparison of a Nicotine Inhaler and Bupropion for Smoking Cessation and Relapse Prevention von Croghan, Ivana T., PhD, Hurt, Richard D., MD, Dakhil, Shaker R., MD, Croghan, Gary A., PhD, MD, Sloan, Jeff A., PhD, Novotny, Paul J., MS, Rowland, Kendrith M., MD, Bernath, Albert, MD, Loots, Mary L., RN, BS, Le-Lindqwister, Nguyet A., MD, Tschetter, Loren K., MD, Garneau, Stewart C., MD, Flynn, Kathleen A., RN, Ebbert, Larry P., MD, Wender, Donald B., MD, Loprinzi, Charles L., MD

Volltext

Tobacco use outcomes among patients with head and neck carcinoma treated for nicotine dependence: A matched-pair analysis von GARCES, Yolanda I, SCHROEDER, Darrell R, NIRELLI, Liza M, CROGHAN, Gary A, CROGHAN, Ivana T, FOOTE, Robert L, HURT, Richard D

Volltext

A randomized trial of naltrexone for smoking cessation von Wong, Gilbert Y., Wolter, Troy D., Croghan, Gary A., Croghan, Ivana T., Offord, Kenneth P., Hurt, Richard D.

Volltext

A phase I and pharmacologic study of sequences of the proteasome inhibitor, bortezomib (PS-341, Velcade™), in combination with paclitaxel and carboplatin in patients with advanced... von MA, Cynthia, MANDREKAR, Sumithra J, ERIICHMAN, Charles, WRIGHT, John J, ADJEI, Alex A, ALBERTS, Steven R, CROGHAN, Gary A, JATOI, Aminah, REID, Joel M, HANSON, Lorelei J, BRUZEK, Laura, TAN, Angelina D, PITOT, Henry C

Volltext

Does smoking reduction result in reduction of biomarkers associated with harm? A pilot study using a nicotine inhaler von Hurt, Richard D., Croghan, Gary A., Wolter, Troy D., Croghan, Ivana T., Offord, Kenneth P., Williams, Gary M., Djordjevic, Mirjana V., Richie, John P., Jeffrey, Alan M.

Volltext

Do patients with schizophrenia receive state-of-the-art lung cancer therapy? A brief report von Mateen, Farrah J., Jatoi, Aminah, Lineberry, Timothy W., Aranguren, Dawn, Creagan, Edward T., Croghan, Gary A., Jett, James R., Marks, Randolph S., Molina, Julian R., Richardson, Ronald L.

Volltext